Παρασκευή 20 Μαΐου 2016

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes

Molecular Therapy 24, 1003 (May 2016). doi:10.1038/mt.2015.227

Authors: Claudia Cavelti-Weder, Katharina Timper, Eleonora Seelig, Cornelia Keller, Martin Osranek, Ute Lässing, Gunther Spohn, Patrik Maurer, Philipp Müller, Gary T Jennings, Joerg Willers, Philippe Saudan, Marc Y Donath & Martin F Bachmann



from Cancer via ola Kala on Inoreader http://ift.tt/1sHXIbU
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου